EN
AR
Coronary IVUS
enterprise imaging platform masthead

See clearly.
Treat optimally.

    Angiography alone is  not enough in PCI 


    Angiography provides information on luminal characteristics of vessels, but does not provide a clear picture of the vessel and disease.


    However, with IVUS guidance you can see more clearly and improve patient outcomes with informed pre-stent planning and post-stent optimization.1

    IVUS icon

    74%

    of the time, IVUS use resulted in a change in PCI strategy2,3,4,5

    Arrow icon

    46%

    Reduction in TVF at 1 year when IVUS was used6,7

    Lower risk icon

    43%

    Lower risk of cardiac death associated with IVUS8

    See clearly and treat optimally with IVUS in a variety of clinical scenarios

    See clearly and treat optimally with IVUS in a variety of clinical scenarios

    Left main

     

    IVUS is an AHA/ACC/SCAI Class IIa recommendation for the assessment of angiographically indeterminant left main CAD.9

    IVUS may help to determine:

    • Lesion significance

    • Vessel sizing

    • Optimal stent deployment

    left main bubble

    Ostial and bifurcation lesions

     

    IVUS guidance reduced long-term all-cause mortality by 76%.10

    IVUS may help to determine:

    • Location of the true ostium to decrease risk of geographic miss

    • Plaque distribution

    • Whether two stents are needed

    • Lesion length

    • Landing zones

    • Whether post-dilation is needed (especially at the proximal stent)

    ambiguous angio gram bubble

    Diffuse disease

     

    Using IVUS for long lesions (stents ≥ 28mm) was associated with a 47% reduction in MACE from 1 to 5 years in the IVUS-XPL randomized control trial.11

    IVUS may help to determine:

    • Vessel size and length of disease

    • Positive remodeling

    • Plaque burden

    • Stenosis

    diffuse disease bubble

    Repeat patients


    IVUS is an AHA/ACC/SCAI Class IIa recommendation to determine the mechanism of stent restenosis.

    IVUS may help to determine:

    • Extent and mechanism of restenosis for optimal treatment strategy and for the decrease of risk of geographic miss

    • Location and amount of thrombus

    ambiguous angio gram bubble

    Ambiguous angiogram

     

    IVUS guidance was associated with less contrast: 20 ml vs. 64.5 ml, p<.001, n=83 patients randomized to IVUS or angiographyguided PCI.12

    IVUS may help to determine:

    • Pathology at the ambiguous site to optimize your treatment strategy

    • Device utilization without additional radiation and contrast

    ambiguous angio gram bubble
    enterprise imaging platform masthead

    IVUS interpretation insights


    IVUS imaging helps you visualize the best path forward. Dive deeper to understand how IVUS imaging works and how to easily interpret vessel morphologies in common clinical scenarios.

    enterprise imaging platform masthead

    Interventional excellence


    Imaging, physiology, co-registration* and software come together to simplify complex interventions, speed routine procedures and provide improved patient care.

    orthopedic surgery trends

    Get advanced insight from your pullback


    Experience the advanced imaging insights from Philips ChromaFlo and IVUS Co-registration and improve your treatment strategies.

    IVUS expert ipad

    Become an IVUS expert


    Advance your IVUS imaging skills with interactive workflows and detailed image interpretation practice. The Philips Coronary IVUS Tutor app is free to download in the App Store or Google Play.

    Cardio app

    Practice using IVUS in cases


    Experience the interactive educational app CardioEx which now features new cases on Philips IVUS, physiology and co-registration. Cardio Ex app is free to download in the App Store or Google Play.

    Philips elite academy logo

    Philips ELIITE Academy is focused on delivering high value and real-time strategic educational programs that meet the evolving needs of our customers. For more information on the available courses, please visit www.igtdacademy.philips.com.

    Keythought leaders icon

    Key thought leaders

    Clinical expertise icon

    Clinical expertise

    Product knowledge icon

    Product knowledge 

    enterprise imaging platform masthead

    Reimbursement and coding resources

    * Co-registration tools available within IntraSight 7 configuration via SyncVision

    1. A. Maehara, M. Matsumura, Z.A. Ali, G.S. Mintz, G.W. Stone. IVUS-guided versus OCT-guided coronary stent implantation. J Am Coll Cardiol Img, 10 (2017), pp. 1487- 1503

    2. Elgendy IY et al. Outcomes with intravascular ultrasound-guided stent implantation: a meta-analysis of randomized trials in the era of drug eluting stents. Circ-Cardiovasc Interv.2016;9:e003700

    3. Ahn JM, Kang SJ, Yoon SH, et al. Meta-analysis of outcomes after intravascular ultrasound-guided versus angiography-guided drug-eluting stent implantation in 26,503 patients enrolled in three randomized trials and 14 observational studies. Am J Cardiol. 2014;113:1338-1347. Hyperlink “http://www.ajconline.org/article/S0002-9149(14)00549-9/abstract”

    4. Witzenbichler B, et al. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: The ADAPT-DES study. Circulation. 2014 Jan:129,4;463-470.

    5. Singh V, Badheka AO, Arora S, et al. Comparison of in-hospital mortality, length of hospitalization, costs, and vascular complications of percutaneous coronary interventions guided by ultrasound versus guided by angiography. Am J Cardiol. Online 18 Feb 2015.

    6. TVF categorized as cardiac death, target vessel MI, and clinical driven TVR

    7. Zhang J et al. The ULTIMATE trial. Journal of the American College of Cardiology (2018), doi.org/10.1016/j.jacc.2018.09.013. , accepted September 13 2018.

    8. Choi K, et al. Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention on Long-Term Clinical Outcomes in Patients Undergoing Complex Procedures. JACC: Cardivascular Interventions. Mar 2019, 4281; DOI: 10.1016/j.jcin.2019.01.227

    9. Levine et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011;124:e574-651]

    10. Kim S, Kim Y, et al. Long-term outcomes of intravascular ultrasound-guided stenting in coronary bifurcation lesions. Am J Cardiol. 2010;106(5):612-8]

    11. Hong S-J, et al. “Effect of Intravascular Ultrasound-guided Drug-Eluting Stent Implantation: Five-Year Follow-Up of the IVUS-XPL Randomized Trial, JACC: Cardiovascular Interventions (2019), doi: https://doi.org/10.1016/j.jcin.2019.09.033

    12. Mariani et al. MOZART study. JACC Interventions 2014; 7:1287-93.

    We are always interested in engaging with you.

    Let us know how we can help.

    1
    Select your area of interest
    2
    Contact details

    You are about to visit a Philips global content page

    Continue

    You are about to visit a Philips global content page

    Continue

    Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.